A detailed history of Great West Life Assurance CO transactions in Vericel Corp stock. As of the latest transaction made, Great West Life Assurance CO holds 61,351 shares of VCEL stock, worth $2.66 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
61,351
Previous 58,377 5.09%
Holding current value
$2.66 Million
Previous $3.04 Million 7.41%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$41.71 - $52.9 $124,045 - $157,324
2,974 Added 5.09%
61,351 $2.81 Million
Q1 2024

May 13, 2024

BUY
$32.52 - $52.33 $137,462 - $221,198
4,227 Added 7.81%
58,377 $3.04 Million
Q4 2023

Feb 13, 2024

SELL
$30.85 - $37.09 $59,386 - $71,398
-1,925 Reduced 3.43%
54,150 $1.93 Million
Q3 2023

Nov 14, 2023

SELL
$31.69 - $39.25 $602 - $745
-19 Reduced 0.03%
56,075 $1.88 Million
Q2 2023

Aug 10, 2023

SELL
$29.0 - $38.37 $47,212 - $62,466
-1,628 Reduced 2.82%
56,094 $2.11 Million
Q1 2023

May 12, 2023

SELL
$23.85 - $31.34 $45,696 - $60,047
-1,916 Reduced 3.21%
57,722 $1.69 Million
Q4 2022

Feb 10, 2023

SELL
$17.65 - $27.37 $1,535 - $2,381
-87 Reduced 0.15%
59,638 $1.57 Million
Q3 2022

Nov 01, 2022

BUY
$22.62 - $32.54 $1.35 Million - $1.94 Million
59,725 New
59,725 $1.39 Million
Q2 2022

Aug 09, 2022

BUY
$22.88 - $39.45 $125,290 - $216,028
5,476 Added 13.58%
45,809 $1.15 Million
Q1 2022

May 12, 2022

BUY
$31.69 - $43.29 $11,566 - $15,800
365 Added 0.91%
40,333 $1.58 Million
Q4 2021

Feb 14, 2022

BUY
$35.2 - $52.6 $6,547 - $9,783
186 Added 0.47%
39,968 $1.57 Million
Q3 2021

Nov 15, 2021

BUY
$46.35 - $59.75 $15,202 - $19,598
328 Added 0.83%
39,782 $1.96 Million
Q2 2021

Aug 11, 2021

BUY
$47.2 - $67.81 $30,774 - $44,212
652 Added 1.68%
39,454 $2.07 Million
Q1 2021

May 17, 2021

BUY
$30.93 - $59.48 $1.12 Million - $2.16 Million
36,340 Added 1476.04%
38,802 $2.16 Million
Q3 2020

Nov 17, 2020

BUY
$14.68 - $19.12 $36,142 - $47,073
2,462 New
2,462 $45,000
Q3 2020

Nov 13, 2020

SELL
$14.68 - $19.12 $36,142 - $47,073
-2,462 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$13.77 - $19.2 $33,901 - $47,270
2,462 New
2,462 $42,000
Q3 2019

Oct 25, 2019

SELL
$14.93 - $19.83 $69,290 - $92,031
-4,641 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$10.77 - $18.44 $49,983 - $85,580
4,641 New
4,641 $78,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.05B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.